Viewing StudyNCT04858334



Ignite Creation Date: 2024-05-06 @ 4:03 PM
Last Modification Date: 2024-10-26 @ 2:03 PM
Study NCT ID: NCT04858334
Status: RECRUITING
Last Update Posted: 2024-07-15
First Post: 2021-04-23

Brief Title: APOLLO A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1 BRCA2 or PALB2 Mutation
Sponsor:
Organization: National Cancer Institute NCI